Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:EDOCNASDAQ:GFGFNASDAQ:MOODNASDAQ:OZEM On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeEDOCGlobal X Telemedicine & Digital Health ETF$10.46+0.7%$9.68$8.50▼$11.91$37.76M0.8823,128 shs9,271 shsGFGFGuru Favorite Stocks ETF$31.95+0.1%$30.43$27.08▼$33.04$33.87M1.081,161 shs156 shsMOODRelative Sentiment Tactical Allocation ETF$32.42-0.1%$31.27$28.10▼$32.44$32.74M0.815,969 shs8,383 shsOZEMRoundhill GLP-1 & Weight Loss ETF$25.10+0.6%$23.46$20.01▼$29.21$36.40MN/A13,252 shs6,220 shsThe Best High-Yield Dividend Stocks for 2025Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceEDOCGlobal X Telemedicine & Digital Health ETF0.00%+2.45%+3.67%+0.97%+15.45%GFGFGuru Favorite Stocks ETF+0.17%+1.78%+3.58%+1.79%+15.07%MOODRelative Sentiment Tactical Allocation ETF+1.47%+1.85%+3.68%+5.87%+12.49%OZEMRoundhill GLP-1 & Weight Loss ETF+1.30%+3.44%-2.39%-1.66%-0.17%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationEDOCGlobal X Telemedicine & Digital Health ETFN/AN/AN/AN/AN/AN/AN/AN/AGFGFGuru Favorite Stocks ETFN/AN/AN/AN/AN/AN/AN/AN/AMOODRelative Sentiment Tactical Allocation ETFN/AN/AN/AN/AN/AN/AN/AN/AOZEMRoundhill GLP-1 & Weight Loss ETFN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceEDOCGlobal X Telemedicine & Digital Health ETF 2.68Moderate Buy$10.46N/AGFGFGuru Favorite Stocks ETF 2.64Moderate Buy$31.95N/AMOODRelative Sentiment Tactical Allocation ETF 0.00N/AN/AN/AOZEMRoundhill GLP-1 & Weight Loss ETF 2.70Moderate Buy$25.10N/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookEDOCGlobal X Telemedicine & Digital Health ETFN/AN/AN/AN/AN/AN/AGFGFGuru Favorite Stocks ETFN/AN/AN/AN/AN/AN/AMOODRelative Sentiment Tactical Allocation ETFN/AN/AN/AN/AN/AN/AOZEMRoundhill GLP-1 & Weight Loss ETFN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateEDOCGlobal X Telemedicine & Digital Health ETFN/AN/A41.46∞N/AN/AN/AN/AN/AGFGFGuru Favorite Stocks ETFN/AN/A28.14∞N/AN/AN/AN/AN/AMOODRelative Sentiment Tactical Allocation ETFN/AN/A17.72∞N/AN/AN/AN/AN/AOZEMRoundhill GLP-1 & Weight Loss ETFN/AN/A22.66∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthEDOCGlobal X Telemedicine & Digital Health ETFN/A0.00%N/AN/AN/AGFGFGuru Favorite Stocks ETF$0.030.09%N/AN/AN/AMOODRelative Sentiment Tactical Allocation ETF$0.391.20%N/AN/AN/AOZEMRoundhill GLP-1 & Weight Loss ETF$0.050.20%N/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipEDOCGlobal X Telemedicine & Digital Health ETFN/AGFGFGuru Favorite Stocks ETFN/AMOODRelative Sentiment Tactical Allocation ETFN/AOZEMRoundhill GLP-1 & Weight Loss ETFN/AInsider OwnershipCompanyInsider OwnershipEDOCGlobal X Telemedicine & Digital Health ETFN/AGFGFGuru Favorite Stocks ETFN/AMOODRelative Sentiment Tactical Allocation ETFN/AOZEMRoundhill GLP-1 & Weight Loss ETFN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableEDOCGlobal X Telemedicine & Digital Health ETF147,0003.61 millionN/AOptionableGFGFGuru Favorite Stocks ETFN/A1.06 millionN/ANot OptionableMOODRelative Sentiment Tactical Allocation ETFN/A1.01 millionN/AN/AOZEMRoundhill GLP-1 & Weight Loss ETFN/A1.45 millionN/AN/AGFGF, EDOC, OZEM, and MOOD HeadlinesRecent News About These CompaniesHow to avoid nausea on Ozempic and GLP-1 medicationsMarch 17, 2025 | msn.comScientists Discover Potential Ozempic Rival That Could Help People Lose Weight With Less NauseaMarch 16, 2025 | gizmodo.comEmployers face pressure to add coverage of Ozempic, other weight-loss drugsMarch 12, 2025 | bizjournals.comHere’s why Ozempic maker’s new weight-loss drug isn’t good enough for investorsMarch 11, 2025 | msn.comNaturally occurring molecule rivals Ozempic in weight loss, sidesteps side effectsMarch 7, 2025 | msn.comMore yogurt and nuts, less alcohol and snack foods: How GLP-1 medications like Ozempic are influencing people’s food spending habitsMarch 5, 2025 | yahoo.com5 Sector ETFs Up 10% Despite February's Market SlumpMarch 3, 2025 | zacks.comDrug compounders sue over weight loss drugs’ removal from FDA shortage listFebruary 25, 2025 | msn.comHow experiments with gila monster venom led to blockbuster weight loss drugs like OzempicFebruary 24, 2025 | whyy.orgWeight-loss drugs aren’t just slimming waists. They’re shifting the economy.February 23, 2025 | washingtonpost.comFDA gives compounders short reprieve as Novo Nordisk GLP-1 supply normalizesFebruary 21, 2025 | seekingalpha.comYearslong shortage of popular weight-loss and diabetes drugs is resolved, FDA saysFebruary 21, 2025 | msn.comNovel antibody could help prevent bone, muscle loss due to GLP-1 drugsFebruary 18, 2025 | medicalnewstoday.comIs Ozempic safe for weight loss? What doctors want you to know about blockbuster drugFebruary 15, 2025 | aol.comWeight-Loss Drugs Like Ozempic Can Help Alcohol AddictionFebruary 13, 2025 | msn.comThe 2 sides of Ozempic — weight loss success stories and health nightmares in KentuckyFebruary 11, 2025 | wdrb.com(OZEM) Investment AnalysisFebruary 1, 2025 | news.stocktradersdaily.comAbout half of Americans approve of using weight-loss drugs to treat obesity, AP-NORC poll findsJanuary 31, 2025 | msn.comOzempic vs. Semaglutide: 10 Weight Loss Medications Compared for 2025January 30, 2025 | omaha.comWhy Weight-Loss Drugs Could Be Game-Changers for Your Investment PortfolioJanuary 30, 2025 | msn.comMedia Sentiment Over TimeGFGF, EDOC, OZEM, and MOOD Company DescriptionsGlobal X Telemedicine & Digital Health ETF NASDAQ:EDOC$10.46 +0.08 (+0.72%) As of 05/30/2025The Global X Telemedicine & Digital Health ETF (EDOC) is an exchange-traded fund that mostly invests in health care equity. The fund tracks a market-cap weighted index of companies in the global health care industry with high exposure to telemedicine & digital health. EDOC was launched on Jul 29, 2020 and is managed by Global X.Guru Favorite Stocks ETF NASDAQ:GFGF$31.95 +0.02 (+0.06%) As of 09:31 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.The Guru Favorite Stocks ETF Guru Favorite Stocks Fund (GFGF) is an exchange-traded fund that mostly invests in total market equity. The fund actively selects US-listed companies that are favored by prominent long-term investors. GFGF was launched on Dec 16, 2021 and is managed by Alpha Architect.Relative Sentiment Tactical Allocation ETF NASDAQ:MOOD$32.42 -0.02 (-0.06%) As of 01:20 PM EasternThe Relative Sentiment Tactical Allocation ETF (MOOD) is an exchange-traded fund that mostly invests in target outcome asset allocation. The fund is an actively managed fund-of-funds that tactically invests in equities, bonds, and gold based on relative sentiment factors. MOOD was launched on May 19, 2022 and is issued by Alpha Architect.Roundhill GLP-1 & Weight Loss ETF NASDAQ:OZEM$25.10 +0.16 (+0.64%) As of 01:23 PM EasternThe Roundhill GLP-1 & Weight Loss ETF (OZEM) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that invests in companies from around the world involved in pharmaceutical drugs and supplements used for weight management. OZEM was launched on May 21, 2024 and is issued by Roundhill. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas 3 Reasons Amazon Could Be the Best Tech Performer in June Applied Digital: CoreWeave’s AI Deal Lights a $7 Billion Fuse Steel Dynamics Shares Climb After Tariff Announcement Palantir Soars on Government Deals as Valuation Debate Lingers Broadcom Earnings Preview: AVGO Stock Near Record Highs Why Super Micro Computer's Upside Could Trigger a Short Squeeze Zscaler Will Hit $360 Soon: Here’s the How and Why Buy The Dip in Okta, There’s Nothing Wrong With the Outlook Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
